Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Ibandronate-Sodium Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Ibandronate Sodium Manufacturers in India Suppliers Ibandronate Sodium Dossage Exporters Distributors Ibandronate Sodium api active pharmaceuticals ingredients Ibandronate Sodium manufacturers Side Effects bulk drugs raw material Dossage Ibandronate Sodium companies Side Effects Dossage Importers Ibandronate Sodium Dossage Ibandronate Sodium Exporters Ibandronate Sodium exporters Dossage FDA Dossage Ibandronate Sodium Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Ibandronate Sodium manufacturing pharmaceutical drugs pharmaceutical intermediates Ibandronate Sodium pharmaceutical chemicals pharmaceutical raw materials Ibandronate Sodium active pharmaceutical ingredients Ibandronate Sodium committee active pharmaceutical ingredients manufacturer Ibandronate Sodium Active Pharmaceutical Ingredients manufacturer Ibandronate Sodium exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Ibandronate Sodium, Ibandronate Sodium manufacturer India, Ibandronate Sodium product, Ibandronate Sodium products, Api preparation, Certificate of Analysis API manufacturer product, Ibandronate Sodium anti ulcer product, Certificate of Origin COA Ibandronate Sodium COS Ibandronate Sodium, pharmaceutical generic, pharmaceutical drug, medical, Ibandronate Sodium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Ibandronate Sodium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Ibandronate Sodium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Ibandronate Sodium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Ibandronate Sodium ingredients, api, HIV Ibandronate Sodium, tablets, capsules, syrup & protein Ibandronate Sodium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Ibandronate Sodium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Ibandronate Sodium WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image Ibandronate Sodium


















 











 

 

HOME >> API >> API List 2 >> Ibandronate Sodium >> Dosage

Ibandronate Sodium CAS Number 138926-19-9

DOSAGE
Ibandronate Sodium
CAS Number 138926-19-9

Adults

PO 2.5 mg once daily or one 150 mg tablet once monthly on the same date of each month. Take at least 60 min before the first food or drink (other than water) of the day or before taking any oral medication or supplement, including antacids, calcium, or vitamins.
Adults

IV 3 mg every 3 mo administered over 15 to 30 sec.
General Advice

* Tablets
* Two tablet strengths are available (2.5 mg tablet for once-daily administration and 150 mg tablet for once-monthly administration). Carefully check tablet to ensure proper dose is being administered.
* Do not administer tablets with any liquid other than plain water. Administration of ibandronate tablets with food, medication, juices, mineral water, coffee, or any other beverage will reduce ibandronate absorption and efficacy.

* Injection
* Injection must be administered IV by a health care provider.
* Administer injection using the enclosed needle.
* Prefilled syringes are for single use only; discard unused portion.
* Do not mix injection with calcium-containing solutions or other IV administered drugs.
* If a dose is missed, administer injection as soon as it can be rescheduled. Schedule subsequent injections every 3 mo from the date of last injection and not more frequently than once every 3 mo.
* Patient must receive supplemental calcium and vitamin D.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo
 

Ibandronate Sodium

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.